There are two principle research applications of the Randomized Controlled Trial (RCT), in proving efficacy of homeopathic practice. Trials measuring effectiveness of homeopathic treatment of diseases are the most familiar and natural-seeming method, but are nevertheless the more difficult of realization. The second is the proving trial, which focuses on the narrower, and presumably easier to judge question whether the homeopathic remedy has any effect of any sort on the human organism. In short, the proving trial is not directly concerned with healing effects of homeopathy, but with the more foundational question, whether there is anything substantial, or “real,” in homeopathic remedies in the first place.
In Part I, following, I will briefly discuss the homeopathic treatment trial, primarily with an aim to identify a few of the key issues that, from the homeopathic point of view, have invalidated trial outcomes in the past. I will not pursue this thorny topic very far, but will be satisfied to identify a few problems that have characterized research trials conducted in this venue to date, in hope that work may begin, in appropriate quarters, to meeting these concerns and to developing more adequate research instruments.
In Part II, the main question of this paper will be addressed, namely, how to design an efficacious trial, that is, an RCT that can claim to measure accurately the effects of homeopathic remedies upon trial participants. Although it is normal to speak of a trial measuring the “efficacy” of a medication, I propose that we are justified, in view of the consistent failure of RCTs to measure any effect in homeopathic remedies, to question the “efficacy” of the RCT itself. This section will conclude with a recommendation – astonishing in its simplicity – that, frankly, should guarantee unmistakable evidence, in fully replicable experimental protocols, in proving trials of the future.
Finally, in Part III, a number of additional questions will be addressed, that should be kept in mind in designing an appropriate RCT. Together, these considerations, with the recommendations included in Part II, provide a range of parameters that should satisfy any critic, that the perspicacious researcher has fulfilled his obligations, to design and implement a credible scientific trial of homeopathy, by combining – at long last – academic and logical scruples, with his technical and statistical finesse.
Part I – Research in Homeopathic Treatment
The problem conducting research into homeopathic treatment is at once easy to define, difficult to understand, simple to rectify in principle, and intractable of resolution in practice. The problem can be stated with reference to the by now trite idea, that homeopathy operates according to a paradigm that is different from the paradigm of conventional (“allopathic”) medicine, and cannot be measured utilizing the same research instruments. This seems the most natural statement of fact to the homeopath, but is infuriating to the research scientist, who protests that, if a school of medicine claims to heal, by whatever means, then it ought to be possible to observe the fact that the patient has been healed – which is all the RCT wants to accomplish.
In fact, the researcher’s objections are perfectly reasonable. But so are the reservations expressed by the homeopath. And the two positions are not even difficult to reconcile, at least in principle, though once again, the hydra headed monster, practicality, laughs implacably at our efforts to find a direct route to a satisfactory conclusion.
Commonly, those skeptical of homeopathic claims will say something to the effect, “let’s design a trial to show that homeopathy can cure high blood pressure.” Of course, any other disease state can be substituted. Immediately, the rejoinder is heard, that homeopathy treats the whole person, that prescriptions in homeopathy are made upon the patient’s totality of symptoms, and not upon a discrete pathological entity. The homeopath concludes, therefore, that it is impossible to test homeopathy in reference to a discrete diagnosis.
However, if one considers choice of words more closely, it will be realized that the conventional, or “allopathic” diagnosis, whatever clinical entity is chosen, is but a different way of referencing what, from the homeopathic point of view, would (or could in some cases) be termed the patient’s “chief complaint.” And, in fact, in homeopathic treatment, therefore, one would expect that the chief complaint, or “presenting diagnosis,” would be resolved, or cured, by the end of a successful course of treatment. The problem arriving at that end, in a research trial, is simply that the trial is not individualized.
This is easy to overcome, as by now has often been observed: select a diagnostic entity to treat, gather a sample population, and allow the homeopaths to treat their patients according to their own methods, individualizing to their heart’s content. In fact, this should work, though it has not as yet been implemented in a way that would truly satisfy the requirements of individualization, in homeopathic practice. In short, to be successful, there are at least three main requirements, in designing such a trial that must be met, to establish efficacy of the trial, that is, to establish that the trial protocol is sufficient to the task of measuring homeopathic action:
First, the homeopaths participating in the study must be adherents of classical methods, of Hahnemannian homeopathy. Such practitioners would pass the ‘test’ of mainstream practice, in adhering to the four basic tenets of classical homeopathy: single remedy, single dose, minimum dose, wait and watch. The reason for insisting on this point, is that there are by now so many variants on classical methods, that we must focus clearly on our task: if we are testing “homeopathy,” then we are not testing combination remedies, preventative homeopathy, homeopathic remedies as specifics, or any number of other derivative practices.
This is not to suggest there is no value in such practices, only that, practically speaking, a research trial will show different treatment results, if different treatment methodologies are used. Now, granted, it may be worthwhile to do research into these other methods, and the variable uses to which homeopathic remedies may be put, but that is not the same as testing homeopathy. Simply put, our ideal research trial must define its terms rigorously, and test what it says it wants to test.